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The SecA2 protein is part of a specialized protein export system of mycobacteria. We set out to identify
proteins exported to the bacterial cell envelope by the mycobacterial SecA2 system. By comparing the protein
profiles of cell wall and membrane fractions from wild-type and secA2 mutant Mycobacterium smegmatis, we
identified the Msmeg1712 and Msmeg1704 proteins as SecA2-dependent cell envelope proteins. These are the
first endogenous M. smegmatis proteins identified as dependent on SecA2 for export. Both proteins are
homologous to periplasmic sugar-binding proteins of other bacteria, and both contain functional amino-
terminal signal sequences with lipobox motifs. These two proteins appeared to be genuine lipoproteins as
shown by Triton X-114 fractionation and sensitivity to globomycin, an inhibitor of lipoprotein signal peptidase.
The role of SecA2 in the export of these proteins was specific; not all mycobacterial lipoproteins required SecA2
for efficient localization or processing. Finally, Msmeg1704 was recognized by the SecA2 pathway of Mycobac-
terium tuberculosis, as indicated by the appearance of an export intermediate when the protein was expressed
in a secA2 mutant of M. tuberculosis. Taken together, these results indicate that a select subset of envelope
proteins containing amino-terminal signal sequences can be substrates of the mycobacterial SecA2 pathway
and that some determinants for SecA2-dependent export are conserved between M. smegmatis and M.
tuberculosis.
Like all bacteria, mycobacteria possess systems to localize
proteins to different subcellular compartments. After synthesis
in the cytoplasm, some proteins are exported to the cytoplas-
mic membrane or cell wall (collectively termed the cell enve-
lope) or to the extracellular environment. Proteins in these
external locations can have important activities in nutrient
acquisition, maintenance of the cell envelope, or interaction
with a host (26). Mycobacteria have several known protein
export pathways that localize proteins to extracytoplasmic lo-
cations, including the general secretion (Sec) pathway (8, 26,
39), the twin-arginine translocation pathway (TAT) (33, 42,
46), and the specialized ESAT-6 secretion system (ESX-1) (15,
19, 22, 43, 53).
The general Sec export pathway is a highly conserved and
essential system of bacteria. In mycobacteria, the Sec pathway
is most likely responsible for the majority of protein export
beyond the cytoplasm. Years of study, primarily in Escherichia
coli, provided advanced understanding of this pathway (for
reviews, see references 12 and 34). Proteins exported by the
Sec pathway are first synthesized as precursors with recogniz-
able amino-terminal signal sequences. These precursors are
translocated in an unfolded state across the cytoplasmic mem-
brane through the concerted action of several Sec proteins.
The SecA ATPase has a central role in this export pathway. It
recognizes the precursor, in some cases with the assistance of
chaperones, and delivers it to the SecYEG pore complex that
spans the cytoplasmic membrane. Through repeated cycles of
ATP hydrolysis, SecA drives export of the precursor through
the SecYEG pore (14, 30). During or immediately following
transport across the membrane, the signal sequence is cleaved
by one of two signal peptidases to produce the mature protein.
A subset of Sec-exported proteins contains a covalently at-
tached lipid that tethers the mature protein to the cell enve-
lope after export. The amino-terminal signal sequence of these
lipoproteins is distinguishable by the presence of a lipobox
motif at the signal sequence cleavage site. A lipobox, usually
defined as (LV)3(AST)2(GA)1C1 (32), includes an in-
variant cysteine at the 1 position of the cleaved mature pro-
tein. This cysteine is also the site of lipid modification. The
lipoprotein signal sequence is cleaved by a lipoprotein-specific
signal peptidase, LspA (57). In E. coli, lipid attachment to the
sulfhydryl of the conserved cysteine is a prerequisite for signal
sequence cleavage by LspA (58), although a recent study in
Listeria monocytogenes revealed that this is not a universal
requirement (5). Mycobacterium tuberculosis also possesses a
functional LspA, which is important for virulence (3, 47).
Mycobacteria possess two nonredundant homologs of SecA
(8, 9). One of the homologs (SecA1) is essential and presum-
ably performs the “housekeeping” role in Sec export; the other
homolog (SecA2) is not essential and promotes export of a
small subset of proteins (8). A subset of gram-positive bacteria
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has also been identified as organisms containing two distinct
SecA homologs, and similarly, one homolog (SecA2) is not
essential and is required for export of a subset of proteins (6,
11, 29). SecA2 has been demonstrated to have a role in the
pathogenesis of both M. tuberculosis and L. monocytogenes (9,
27, 28). Examples of proteins identified as proteins exported by
various SecA2 systems include extracellular secreted proteins,
as well as cell envelope proteins. Some of these SecA2-depen-
dent exported proteins contain recognizable signal sequences,
and others do not (2, 6, 9, 11, 28). In the past, we searched for
secreted proteins of M. tuberculosis that depend on SecA2 for
extracellular release. Comparison of the proteins secreted into
culture media by wild-type and secA2 mutant strains of M.
tuberculosis identified a small number of proteins affected by
SecA2 (9). Two of the M. tuberculosis proteins dependent on
SecA2 for secretion are superoxide dismutase (SodA) and
catalase/peroxidase (KatG), neither of which has a discernible
amino-terminal signal sequence.
Here we expanded our search for mycobacterial SecA2-
dependent exported proteins to the cell envelope of the fast-
growing model organism Mycobacterium smegmatis. We com-
pared subcellular fractions of wild-type and secA2 mutant
strains of M. smegmatis and identified two proteins, Msmeg1712
and Msmeg1704, that depend on SecA2 for correct localization to
the cell envelope. Both of these proteins are homologs of
periplasmic sugar-binding proteins with likely roles in sugar up-
take. We further demonstrated that both Msmeg1712 and
Msmeg1704 are lipoproteins by using, for the first time in
mycobacteria, the lipoprotein signal peptidase inhibitor globo-
mycin (13, 58). The role of SecA2 in export of Msmeg1712 and
Msmeg1704 is specific, since we noted no global effect on cell
envelope proteins or lipoproteins in the secA2 mutant. The
SecA2 system of M. tuberculosis also recognized Msmeg1704,
as shown by a defect in precursor processing when it was
expressed in a secA2 mutant of M. tuberculosis. These results
expand our understanding of the types of substrates exported
by SecA2 in mycobacteria.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The mycobacterial strains used in this
study are listed in Table 1. E. coli strain DH5 was used for DNA cloning and
was grown in Luria-Bertani medium (Fisher). M. smegmatis strains were grown
at 37°C in Middlebrook 7H9 medium (Difco) containing 0.2% glucose, 0.5%
glycerol, and 0.1% Tween 80 or in Mueller-Hinton broth (Difco) containing
0.1% Tween 80 to the mid-log phase (optical density at 600 nm [OD600], 0.6 to
1.0) prior to harvesting by centrifugation. M. tuberculosis strains were grown at
37°C in 7H9 medium containing albumin-dextrose-saline enrichment (final con-
centrations, 5 g/liter bovine serum albumin [fraction V], 2 g/liter dextrose, and 50
mM NaCl), 0.05% Tween 80, plus 0.5% glycerol. When necessary, kanamycin (20
g/ml for M. smegmatis and M. tuberculosis or 40 g/ml for E. coli) or hygromycin
(50 g/ml for M. smegmatis or 150 g/ml for E. coli) was used. Strains expressing
hemagglutinin (HA)-tagged Msmeg1712 (Msmeg1712-HA) and Msmeg1704-HA
were grown at 30°C.
Reagents. Triton X-100, Triton X-114, and urea (electrophoresis grade) were
obtained from Sigma. Triton X-100 was kept as a 10% stock solution in water and
mixed with Amberlite MB-150 mixed-bed ion-exchange resin prior to use in
two-dimensional (2D) gels. Carrier ampholytes were obtained from Bio-Rad
(BioLytes 3-10, 6-8, and 5-7 range). Globomycin was a generous gift from
Masatoshi Inukai (Sankyo Corporation and International Union of Health and
Welfare, Japan).
Subcellular fractionation. Crude cell wall, membrane, and soluble fractions
were prepared by differential ultracentrifugation as described in previously pub-
lished work (18, 45). Briefly, mycobacterial cultures (250 ml) were harvested by
centrifugation at 3,000  g. Cell pellets (approximately 0.5 g [wet weight]) were
washed with phosphate-buffered saline (PBS) and stored at 80°C. For M.
tuberculosis, cell pellets were sterilized by gamma-irradiation in a JL Shephard
Mark I 137Cs irradiator (Department of Radiobiology, University of North Caro-
lina at Chapel Hill) with a dose of 2.4 megarads. All subsequent steps were
performed at 4°C. Pellets were resuspended in 4 ml of breaking buffer (PBS, 1
mM phenylmethylsulfonyl fluoride, 0.6 g/ml each of DNase and RNase, and a
cocktail of protease inhibitors [2 g/ml each of aprotinin, E-64, leupeptin, and
pepstatin A and 100 g/ml Pefabloc SC]). Cells were lysed by passage through a
French pressure cell (five times at 20,000 lb/in2). Unbroken cells were pelleted at
3,000  g for 20 min to generate a clarified whole-cell lysate, which was centri-
fuged at 27,000  g for 30 min to pellet the cell wall. The supernatant was
centrifuged at 100,000  g for 2 h to separate the membrane fraction from the
soluble fraction. The cell wall and membrane fractions were washed once in PBS.
Protein concentrations were estimated using the Bio-Rad protein assay.
2D-PAGE analysis. Polyacrylamide tube gels (38) in a Bio-Rad minitube cell
were used to perform 2D polyacrylamide gel electrophoresis (2D-PAGE) of
membrane and cell wall fractions. Tube gels (4% polyacrylamide, 8 M urea, 2%
Triton X-100, 0.4% [wt/vol] BioLytes 3-10, 0.8% [wt/vol] each BioLytes 5-7 and
6-8) were polymerized overnight. Fifty to 100 g of membrane or cell wall
protein was resuspended in a 2D-PAGE buffer (8 M urea, 2% Triton X-100, 1%
[wt/vol] dithiothreitol, 1% BioLytes 3-10) and loaded into the sample cup of the
tube gel apparatus. Proteins were focused in the first dimension for 6 h at 500 V.
Tube gels were equilibrated in 4 sodium dodecyl sulfate (SDS)-PAGE loading
buffer containing 20 mM dithiothreitol and placed on top of conventional 15%
SDS-PAGE minigels with 4% stacking gels. Gels were stained with Coomassie
brilliant blue R-250.
Triton X-114 partitioning. The methods used for detergent partitioning ex-
periments were adapted from the methods of Young and Garbe (61). French-
pressed whole-cell lysate was diluted to 2 mg/ml in 1 ml of PBS containing 4%
(vol/vol) Triton X-114 and a protease inhibitor cocktail (see above). Lipoproteins
were extracted for 2 h at 4°C on a rocking platform. Insoluble material was
removed by centrifugation at 12,000  g for 10 min. The insoluble pellet was
reextracted with cold PBS-4% Triton X-114. Pooled supernatants were brought
to 37°C for 5 min to allow for phase separation and then centrifuged at 12,000 
g for 5 min to partition the phases. The detergent phase was washed twice with
PBS and precipitated with 9 volumes of acetone at 20°C overnight. Acetone-
precipitated proteins were pelleted at 12,000  g and washed twice with cold
acetone. Proteins were resuspended in SDS-PAGE sample buffer and separated
by one-dimensional (1D) SDS-PAGE (1D-PAGE).
Mass spectrometric identification of proteins. Protein spots were cut from a
gel, minced, and subjected to in-gel digestion with trypsin using an Investigator
Progest (Genomic Solutions, Ann Arbor, MI) robotic digester. Following elution
from the gel, the tryptic peptides were lyophilized and resuspended in 50%
methanol-0.1% formic acid and spotted (1:1, vol/vol) with a saturated solution of
TABLE 1. Strains used in this study
Strain Genotype Referenceor source
M. smegmatis
mc2155 ept-1 50
mc22522 mc2155, secA2 8
MYA018 mc22522, pYA810 This study
SG025 mc2155, pMV306.kan This study
SG026 mc22522, pMV306.kan This study
SG050 mc2155, pHSG54 This study
SG051 mc22522, pHSG54 This study
SG046 mc2155, pHSG58 This study
SG047 mc22522, pHSG58 This study
SG054 mc2155, pHSG67 This study
SG055 mc22522, pHSG67 This study
SG056 mc2155, pYUB76 This study
SG058 mc2155, pHSG62 This study
SG059 mc22522, pHSG62 This study
SG065 mc2155, pML440 This study
SG066 mc22522, pML440 This study
SG075 mc2155, attB::PMsmeg1712-msmeg1712-HA aph This study
SG076 mc22522, attB::PMsmeg1712-msmeg1712-HA aph This study
M. tuberculosis
H37Rv Virulent lab strain ATCC
mc23112 H37Rv, secA2 9
MBTB51 H37Rv, pHSG58 This study
MBTB52 mc23112, pHSG58 This study
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-cyano-4-hydroxycinnamic acid in 50% acetonitrile-0.1% trifluoroacetic acid.
Spots were analyzed by matrix-assisted laser desorption ionization mass spec-
trometry and matrix-assisted laser desorption ionization mass spectrometry/mass
spectrometry with an ABI 4700 proteomics analyzer (Framingham, MA) in the
positive ion mode. Spectra were searched against a database of the M. smegmatis
predicted open reading frames (www.tigr.org) using GPS software and the
MASCOT (40) search engine. All analyses were performed at the Michael
Hooker Proteomics Core Facility at the University of North Carolina at Chapel
Hill.
Plasmid construction. Plasmids used in this study are listed in Table 2. Oli-
gonucleotide primers used to amplify DNA sequences for subcloning are listed
in Table 3. All plasmid inserts were sequenced and shown to be error free.
Plasmids were electroporated into M. smegmatis or M. tuberculosis as previously
described (7).
(i) Construction of an integrating M. smegmatis secA2 complementation vec-
tor. The secA2 gene of M. smegmatis was cloned from pMB208 (8) as a BamHI
fragment into similarly digested pMV306.kan to generate pYA810.
(ii) Construction of an Msmeg1712-HA expression vector. A DNA fragment
containing the msmeg1712 gene, the upstream 399 bp containing the promoter,
and a C-terminal HA tag was amplified from M. smegmatis genomic DNA using
an Expand high-fidelity polymerase kit (Roche) with primers Msmeg1712-3 and
Msmeg1712-Prom-2. Primer Msmeg1712-3 includes the sequence encoding the
HA tag. The fragment was cloned into pCR2.1-TOPO using Topo-TA cloning
(Invitrogen) to make pHSG83 and then subcloned as a NotI-HindIII fragment
into similarly digested pMV306.kan to make pHSG84. M. smegmatis strains
containing pHSG84 were grown in Mueller-Hinton broth to induce expression.
(iii) Construction of an Msmeg1704-HA expression vector. The msmeg1704
gene was cloned by PCR from M. smegmatis genomic DNA using primers
Msmeg1704-1 and Msmeg1704-2. The PCR product was cloned into pCR2.1-
TOPO to make pHSG56. The gene was then subcloned as a SmaI-EcoRI frag-
ment between the EcoRI and MscI sites of pJSC77 (17) to make pHSG58.
(iv) Construction of a (ss)-Msmeg1712 expression vector. A fragment of the
msmeg1712 gene lacking the codons for the predicted signal sequence was PCR
amplified with a C-terminal HA epitope tag from genomic DNA using primers
Msmeg1712-3 and Msmeg1712-5 and cloned into pCR2.1-TOPO to generate
pHSG47. The fragment containing the (ss)-msmeg1712-HA gene was sub-
cloned as a StuI-EcoRI fragment into pMV261.kan cut with MscI and EcoRI to
make pHSG54.
(v) Construction of a 19-kDa lipoprotein (LpqH) expression vector. An over-
lap extension PCR strategy was used to construct a 19-kDa lipoprotein (LpqH)
expression vector. A PCR product containing 521 bp of sequence derived from
pMV261.kan, including the mycobacterial hsp60 promoter, was amplified using
primers Hsp60-Fwd and LpqH-261-1; the latter primer contains 20 bp of se-
quence derived from the 5 end of the lpqH gene. A second PCR product
containing the full-length lpqH gene was amplified from M. tuberculosis genomic
DNA using primers LpqH-Fwd and LpqH-Rev. The PCR products were purified
with QiaQuick PCR purification (QIAGEN) and then annealed by means of the
20 bp of overlapping sequence and amplified using primers Hsp60-Fwd and
LpqH-Rev. The resulting product was cloned into pCR2.1-TOPO to make
pHSG65 and then subcloned as a NotI-EcoRI fragment into similarly digested
pMV261.kan to make pHSG67.
(vi) Construction of an msmeg1712 promoter fusion to lacZ. The 399-bp
intergenic region between the msmeg1712 and msmeg1713 genes, along with the
first 10 codons of msmeg1712, was amplified by PCR using primers Msmeg1712-
Prom-1 and Msmeg1712-Prom-2, cloned into pCR2.1-TOPO to make pHSG61,
and subcloned as a BamHI fragment into pYUB76 (4). The resulting vector
(pHSG62) has the predicted promoter region and first 10 codons of the
msmeg1712 gene fused in frame to the promoterless lacZ reporter gene.
-Galactosidase assays. Cultures were grown to saturation and then diluted
back and grown to the mid-log phase, and -galactosidase activity was measured
using o-nitrophenyl--D-galactoside as described by Alland et al. (1).
Immunoblots. Subcellular fractions were boiled in SDS-PAGE sample buffer,
separated by 1D-PAGE, and transferred to nitrocellulose (Schleicher & Schuell).
The following antibodies were used in immunoblots: anti-HA (Covance) used at
a 1:10,000 dilution, anti-PhoA (Research Diagnostics International) used at a
1:20,000 dilution, anti-19-kDa (provided by Douglas Young) used at a 1:20,000
dilution, IT-23/TB71 antibody (obtained from John Belisle through the TB
Vaccine Testing and Research Materials Contract) used at a 1:100 dilution to
detect PhoS1 (38-kDa protein), and HAT5/IT-64 antibody (obtained from the
TABLE 2. Plasmids used in this study
Plasmid Genotype Description Referenceor source
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle vector with hsp60 promoter 54
pMV306.kan aph int attP ColE1 Single-copy mycobacterial shuttle vector 54
pJSC77 aph oriM ColE1 Phsp60-HA HA tag cloned into pMV261.kan 17
pCR2.1-TOPO aph bla ColE1 TA cloning vector Invitrogen
pYA810 aph Phsp60-secA2 int attP ColE1 Integrating M. smegmatis secA2 complementation plasmid This study
pHSG47 aph bla (ss)-msmeg1712-HA ColE1 Truncated msmeg1712-HA cloned into pCR2.1
pHSG54 aph Phsp60-(ss)-msmeg1712-HA oriM ColE1 (ss)-Msmeg1712-HA expression vector This study
pHSG56 aph bla msmeg1704 ColE1 msmeg1704 open reading frame cloned into pCR2.1 This study
pHSG58 aph Phsp60-msmeg1704-HA oriM ColE1 Msmeg1704-HA mycobacterial expression vector This study
pHSG61 aph bla Pmsmeg1712 ColE1 399-bp intragenic region between msmeg1712 and msmeg1715
cloned into pCR2.1
This study
pHSG62 aph Pmsmeg1712-lacZ oriM ColE1 lacZ under control of msmeg1712 upstream sequence This study
pHSG65 aph bla Phsp60-lpqH ColE1 Fusion of hsp60 promoter to M. tuberculosis lpqH (19-kDa
lipoprotein) gene cloned into pCR2.1
This study
pHSG67 aph Phsp60-lpqH oriM ColE1 M. tuberculosis 19-kDa lipoprotein expression vector This study
pHSG83 aph bla Pmsmeg1712-msmeg1712-HA ColE1 msmeg1712 promoter and open reading frame cloned with
HA tag into pCR2.1
This study
pHSG84 aph Pmsmeg1712-msmeg1712-HA int attP ColE1 Msmeg1712-HA expression vector, native promoter This study
pML440 hyg Pimyc-phoAMsmeg oriM ColE1 Multicopy phoAMsmeg expression vector, imyc promoter 59
pYUB76 aph lacZ oriM ColE1 Multicopy mycobacterial shuttle vector with promoterless
lacZ gene
4
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World Health Organization collection) used at a 1:100 dilution to detect
GroEL2. For MspA immunoblots, fractions were boiled in 80% dimethyl sul-
foxide prior to SDS-PAGE, and MspA monomers were detected using anti-
MspA antiserum at a 1:2,000 dilution (36).
Globomycin treatment of M. smegmatis. Cultures (5 ml) of M. smegmatis were
grown to saturation and then diluted to an OD600 of 0.15 and grown for 8 h in
the presence of 50 g/ml globomycin. Whole-cell lysates were prepared by bead
beating and separated by SDS-PAGE. Proteins were visualized by immunoblot-
ting. For fractionation experiments with globomycin-treated cells, strains ex-
pressing Msmeg1712-HA were grown in 50-ml cultures that were grown over-
night to an OD600 of 0.6 to 0.8 in the presence of 20 g/ml globomycin. Cells
were washed and resuspended in 2 ml breaking buffer prior to lysis in a French
pressure cell.
RESULTS
Identification of SecA2-dependent proteins in the cell enve-
lope of M. smegmatis. To generate cell wall, cytoplasmic mem-
brane, and soluble fractions of M. smegmatis, we followed the
protocol of Roberts et al. that was previously used for frac-
tionation of M. tuberculosis lysed in a French pressure cell (18,
45). In 1D-PAGE analyses (Fig. 1), the protein profile of each
fraction was unique, with the soluble fractions resembling the
whole-cell lysate. In this study we analyzed the subcellular
fractions from three M. smegmatis strains: wild type strain
SG025, the secA2 mutant SG026, and complemented mutant
strain MYA810.
Evaluation by 1D-PAGE of fractions prepared from strains
grown in rich Mueller-Hinton medium revealed two proteins in
both the cell wall and membrane fractions of wild-type M.
smegmatis that were diminished or absent in the corresponding
fractions of the secA2 mutant (Fig. 1). Complementation of
the secA2 mutation with an integrated plasmid expressing M.
smegmatis secA2 restored these proteins to the cell envelope
fractions, which demonstrated that the secA2 mutation was
responsible for their absence in these fractions.
To improve resolution of the SecA2-dependent bands, frac-
tions were separated by 2D-PAGE. Comparison of the 2D
profiles of the M. smegmatis cell wall and membrane fractions
from the wild-type, secA2 mutant, and complemented mutant
strains (Fig. 2) revealed two spots in both fractions that were
SecA2 dependent. The observed molecular masses (	40 and
FIG. 1. 1D-PAGE reveals SecA2-dependent differences in protein
profiles. M. smegmatis wild-type strain SG025 (WT), secA2 mutant
SG026 (), and complemented secA2 mutant MYA810 (c) were
grown in Mueller-Hinton medium, disrupted in a French press, and
fractionated by differential ultracentrifugation. (A) Proteins from
whole-cell lysate (WCL), cell wall (CW), membrane (M), and soluble
(Sol) fractions were solubilized in SDS-PAGE sample buffer and an-
alyzed on a 10 to 20% gradient 1D-PAGE gel. The arrows indicate the
positions of SecA2-dependent protein bands; 120 g protein was
loaded in each lane. (B) Expanded view of the gel region containing
SecA2-dependent proteins (arrows). A representative gel from three
independent experiments is shown.
FIG. 2. 2D-PAGE analysis of cell wall and membrane fractions
reveals SecA2-dependent proteins. Proteins (50 g) from the cell wall
and membrane fractions derived from the M. smegmatis wild type
(WT), secA2 mutant (), and complemented secA2 mutant (c)
were resolved by 2D-PAGE. The relevant region of the protein profile
for each strain is expanded in the boxes on the right. Protein spots that
were reproducibly diminished in the secA2 mutant and restored in
the complemented strain are indicated by arrows. The small boxes
mark the expected positions of the SecA2-dependent spots in the
secA2 mutant. Spots 1 and 2 were identified as Msmeg1712 and
Msmeg1704, respectively. Representative gels from one of three inde-
pendent experiments are shown.
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	45 kDa for spots 1 and 2, respectively) corresponded to the
SecA2-dependent proteins observed in the 1D analysis. A pep-
tide mass fingerprint was generated using matrix-assisted laser
desorption ionization–time of flight mass spectrometry. The
MASCOT algorithm (40) was used to identify the correspond-
ing coding sequence in the M. smegmatis genome, which was
obtained from the Comprehensive Microbial Resource at www
.tigr.org (41). Spots 1 and 2 were identified as Msmeg1712
(GenBank accession no. ABK75924) and Msmeg1704 (GenBank
accession no. ABK76012) with sequence coverage of 73 and
67%, respectively. Using the LIPOP algorithm (23), both
Msmeg1712 and Msmeg1704 were predicted to have amino-
terminal signal sequences with a lipobox motif (see Fig. S1A in
the supplemental material), which suggested that they are ex-
ported lipoproteins subject to signal sequence cleavage during
export.
Similarity between Msmeg1712 and Msmeg1704 and pre-
dicted function in sugar uptake. Msmeg1712 and Msmeg1704
exhibit 23% identity and 40% similarity to each other on the
protein level. Furthermore, both proteins have strong homol-
ogy to periplasmic monosaccharide-binding proteins of bacte-
ria. Msmeg1712 is 63% similar to YtfQ and 49% similar to
RbsB of E. coli, while Msmeg1704 is 80% similar to the ChvE
protein of Agrobacterium tumefaciens. YtfQ, RbsB, and ChvE
have all been shown to either bind or sense monosaccharides
(Richard Horler and Gavin Thomas, personal communication)
(10, 31). An additional similarity is the genomic location of
msmeg1712 and msmeg1704. They are located in adjacent, con-
vergently transcribed predicted operons along with genes en-
coding putative transmembrane permeases and ATP-binding
proteins. The observed homology to sugar-binding proteins
and the genomic organization with ABC transporters strongly
suggest that this genomic region functions in monosaccharide
binding and uptake (see Fig. S1B in the supplemental mate-
rial).
Regulation of Msmeg1712 and Msmeg1704 by glucose and
glycerol. Unlike our findings with cells grown in Mueller-Hin-
ton broth (Fig. 1 and 2), no obvious differences were found in
the subcellular fractions of the wild-type and secA2 mutant
strains grown in minimal Middlebrook 7H9 medium. Further,
although Msmeg1712 and Msmeg1704 were prominent spots
in 2D profiles from Mueller-Hinton medium-grown cultures,
they were absent in 2D profiles from 7H9 medium-grown cul-
tures (data not shown). Because protein homology predicted
that Msmeg1712 and Msmeg1704 have roles in sugar utiliza-
tion, we hypothesized that expression of msmeg1712 is regu-
lated by sugar composition that is different in 7H9 medium and
Mueller-Hinton medium. To test for differential expression in
the two media, we constructed plasmid pHSG62, which has the
399-bp upstream region along with the first 10 codons of
msmeg1712 transcriptionally and translationally linked to a
lacZ reporter. We found that the -galactosidase activity pro-
duced by wild-type M. smegmatis carrying pHSG62 was approx-
imately fourfold higher in Mueller-Hinton medium than in
7H9 medium. Furthermore, supplementation of Mueller-Hin-
ton medium with glucose and glycerol to mimic the carbohy-
drate composition of 7H9 medium repressed msmeg1712-lacZ
expression (Fig. 3). Analysis of a wild-type strain containing
the promoterless lacZ vector yielded no detectable activity
under all conditions. These results demonstrate that the ex-
pression of Msmeg1712 is regulated by the carbon source,
which is consistent with the proposal that these open reading
frames function in sugar catabolism. Notably, the secA2 mu-
tation did not have an effect on expression of msmeg1712-
lacZ.
Immunoblot analysis confirms a role for SecA2 in the export
of Msmeg1712 and Msmeg1704. To confirm and extend the
results obtained from the proteomic analysis, we studied the
subcellular distribution of HA epitope-tagged Msmeg1712 and
Msmeg1704 proteins expressed in the wild type and the secA2
mutant using immunoblotting. Expression of Msmeg1704-HA
was achieved by cloning msmeg1704 under the control of the
mycobacterial hsp60 promoter (54) and growing the strains in
7H9 medium. Because of difficulty expressing Msmeg1712
from the hsp60 promoter, Msmeg1712-HA was expressed from
the native msmeg1712 promoter, and all experiments with this
construct were performed with strains grown in Mueller-Hin-
ton medium to obtain expression.
Comparison of whole-cell lysates revealed equal amounts of
HA-tagged protein in the wild-type and secA2 mutant strains,
ruling out the possibility that the SecA2-dependent differences
in our envelope fractions were due to altered expression of the
msmeg1712 and msmeg1704 genes (Fig. 4A, top two panels,
lanes 1 and 2). Careful comparison of the whole-cell lysates of
the wild-type and secA2 mutant strains revealed that the
HA-tagged protein observed in the secA2 mutant migrated
slower on 1D-PAGE gels. This was most evident with Msmeg
1712-HA (Fig. 4B, lanes 1 and 2). The simplest explanation for
the slower-migrating species in the secA2 mutant is that un-
cleaved precursor protein (form P) accumulates in the absence
of SecA2, whereas in the wild-type strain Msmeg1712-HA and
Msmeg1704-HA are fully processed to the cleaved, lipidated
mature form (form M). Evaluation of cell wall, membrane, and
soluble fractions revealed additional SecA2-dependent differ-
FIG. 3. Carbon source-dependent expression of Msmeg1712. Ex-
pression of the promoterless lacZ gene in pYUB76 (far left) or a fusion
of the lacZ reporter to the 399-bp region upstream of msmeg1712,
containing the putative promoter, was measured in various media by
measuring hydrolysis of o-nitrophenyl--D-galactoside. Where indi-
cated, Middlebrook 7H9 or Mueller-Hinton medium was supple-
mented with 0.2% glucose and 0.5% glycerol. The results are from a
representative experiment performed in triplicate. The error bars rep-
resent standard deviations. WT, wild type; , secA2 mutant.
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ences for Msmeg1712-HA and Msmeg1704-HA. In the ab-
sence of SecA2, the amount of Msmeg1712-HA and Msmeg
1704-HA in the cell wall was significantly reduced (Fig. 4A,
lanes 3 and 4). The absence of SecA2 also resulted in a reduced
abundance of Msmeg1704-HA in the membrane (Fig. 4A,
lanes 5 and 6). While the total amount of membrane-associ-
ated Msmeg1712-HA did not appear to be affected, the
amount of form M was reduced. Slower-migrating species of
both Msmeg1712-HA and Msmeg1704-HA were observed in
the secA2 mutant membranes. These species were quite
prominent in the case of Msmeg1712-HA, and two species
were detected (Fig. 4B). We termed these aberrant species
forms P and X, with form X being the slowest-migrating spe-
cies. As discussed below, we propose that forms P and X
represent uncleaved export intermediates that differ in lipida-
tion. The fact that form X was evident only in the enriched
membrane fraction indicated that it is a relatively rare species
in the total protein that is specifically associated with mem-
branes.
In contrast to the diminished levels of Msmeg1712-HA and
Msmeg1704-HA in the envelope fractions derived from the
secA2 mutant, the soluble fraction of the secA2 mutant had
an increased amount of Msmeg1712-HA and Msmeg1704-HA
(Fig. 4A, lanes 7 and 8) that migrated like form P (Fig. 4B).
This is consistent with a role for SecA2 in export of these
proteins, in that a lack of SecA2 leads to the accumulation of
a putative precursor in the soluble cytosolic fraction. Together,
these results demonstrate that SecA2 is required for efficient
localization of Msmeg1712 and Msmeg1704 to cell envelope
fractions. In addition, the absence of SecA2 results in the
accumulation of Msmeg1712-HA and Msmeg1704-HA in the
soluble fraction and the appearance of export intermediates.
We also expressed a truncated (ss)-Msmeg1712-HA pro-
tein lacking the predicted amino-terminal signal sequence in
the wild-type and secA2 strains. Analysis of subcellular frac-
tions from these strains showed that the truncated protein was
present at equal levels and present exclusively in the soluble
fraction of both strains, demonstrating that the signal sequence
is required for envelope localization of Msmeg1712. As con-
trols for our fractionation, we also localized GroEL2, a cyto-
plasmic protein (51), and MspA, a cell wall protein (52), in the
fractions by immunoblot analysis. As anticipated, GroEL2 was
absent from the envelope fractions and MspA was restricted to
the cell wall fraction. This indicates that there was minimal
contamination of our envelope fractions with soluble protein
and that there was minimal contamination of membrane or
soluble fractions with cell wall protein.
Msmeg1712 and Msmeg1704 behave as lipoproteins in Tri-
ton X-114 fractionation. To validate the bioinformatic predic-
tion that Msmeg1712 and Msmeg1704 were lipoproteins, we
performed Triton X-114 fractionation. Triton X-114 extraction
is a commonly used method for the enrichment of lipoproteins,
since this subclass of proteins partitions into the detergent
phase, whereas soluble proteins remain in the aqueous phase
(61). Triton X-114 extraction of whole-cell lysates of the wild
type, the secA2 mutant, and the complemented mutant re-
vealed multiple proteins in the detergent phase. The majority
of these proteins were equally abundant in the Triton X-114
fraction from the wild type and the secA2 mutant. However,
we routinely detected one 	40-kDa SecA2-dependent protein
in the Triton X-114 fraction. Peptide mass fingerprinting iden-
tified this protein as Msmeg1712 (Fig. 5A). In some experi-
ments a second SecA2-dependent band with the apparent
molecular weight of Msmeg1704 was visible (data not shown).
Triton X-114 extraction of a lysate from wild-type M. smeg-
matis expressing Msmeg1712-HA demonstrated that the
tagged protein also partitions into the detergent phase. In
comparison, when the protein was expressed in the secA2
mutant, less of the protein was present in the Triton X-114
phase and the protein was observed in the aqueous phase,
suggesting that there was loss of lipoprotein characteristics
(Fig. 5B). The same was true for Msmeg1704-HA, although
the effect of SecA2 on localization to the detergent phase was
FIG. 4. SecA2-dependent export of Msmeg1712-HA and Msmeg
1704-HA. (A) M. smegmatis wild type (WT) and the secA2 mutant
() expressing Msmeg1712-HA, Msmeg1704-HA, truncated ss-
Msmeg1712-HA, M. tuberculosis 19-kDa lipoprotein, or M. smegmatis
alkaline phosphatase (PhoAMsmeg) were subjected to subcellular frac-
tionation. The fractions were separated by 1D-PAGE and analyzed by
immunoblotting. The subcellular pattern of GroEL2 and the major M.
smegmatis porin (MspA) expressed from the native chromosomal pro-
moters was also evaluated. The material loaded in each lane corre-
sponded to protein derived from the same number of cells, except for
Msmeg1712-HA, for which the cell wall (CW) and membrane
(M) fractions were loaded with 0.7 cell equivalent relative to the
whole-cell lysate (WCL) and soluble (Sol) fractions. In all cases, the
same amount of protein was loaded for a given fraction of the wild type
and the secA2 mutant. Each blot is representative of at least two
independent experiments. (B) Comparison of the migration of
Msmeg1712-HA forms in selected whole-cell lysate, membrane, or
soluble fractions from wild-type and secA2 mutant strains: forms M
(mature), P (unlipidated, uncleaved precursor), and X (lipidated, un-
cleaved precursor).
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less dramatic, as observed in multiple experiments. As a con-
trol for the Triton X-114 extraction, the well-characterized
19-kDa lipoprotein of M. tuberculosis was expressed in M.
smegmatis. The 19-kDa lipoprotein partitioned to the deter-
gent phase, as previously described (Fig. 5B) (61). These re-
sults suggest that Msmeg1712 and Msmeg1704 are lipoproteins
and that SecA2 is required for efficient lipidation and export of
these proteins.
Msmeg1712 and Msmeg1704 behave as lipoproteins in the
presence of globomycin. To provide additional evidence that
Msmeg1712 and Msmeg1704 are lipoproteins, we grew strains
expressing the proteins in the presence of globomycin, a spe-
cific inhibitor of the lipoprotein signal peptidase (LspA) (13,
56, 57). While globomycin is lethal to gram-negative bacteria,
gram-positive bacteria, including Corynebacterium glutamicum,
can grow in its presence (25, 49). Since the nonessential LspA
protein of M. tuberculosis was previously shown to function in
processing of mycobacterial lipoproteins, we reasoned that
globomycin could be used in mycobacteria to inhibit lipopro-
tein processing (3, 47). We confirmed this by treating M. smeg-
matis expressing the 19-kDa lipoprotein of M. tuberculosis with
globomycin. The 19-kDa lipoprotein was previously shown to
be subject to LspA cleavage (47). Globomycin did not inhibit
growth of M. smegmatis at concentrations up to 50 g/ml, but
it did lead to a shift toward a higher-molecular-weight species
for the 19-kDa lipoprotein (Fig. 6B). The globomycin-depen-
dent mobility shift of the 19-kDa lipoprotein demonstrated
that globomycin affects lipoprotein processing in mycobacteria.
A more pronounced shift was probably masked by the glyco-
sylated nature of the 19-kDa lipoprotein, which complicates
resolution of the protein by SDS-PAGE. When wild-type
strains of M. smegmatis expressing Msmeg1712-HA or
Msmeg1704-HA were treated with globomycin, similar shifts in
mobility were observed (Fig. 6B). In contrast, migration of the
(ss)-Msmeg1712-HA protein lacking the signal sequence
and monomeric MspA, which has a conventional signal se-
quence lacking a lipobox (36), was not affected by globomycin
(Fig. 6B and data not shown). These results provide further
support for the hypothesis that Msmeg1712 and Msmeg1704
are lipoproteins and, more specifically, are subject to LspA
cleavage.
We also evaluated subcellular fractions of globomycin-
treated and untreated strains expressing Msmeg1712-HA.
These experiments again revealed globomycin sensitivity of the
Msmeg1712-HA protein expressed in wild-type M. smegmatis
(Fig. 6C, lanes 1 and 2). In contrast, globomycin had a minimal
effect on the secA2 mutant, and it specifically did not influ-
ence form P or X, indicating that both of these forms are
uncleaved precursors. Interestingly, the globomycin-shifted
species of the wild type comigrated with form X of Msmeg
1712-HA in the secA2 mutant (Fig. 6C, lanes 2, 9, 10, 11, and
12). At least in E. coli, lipid modification precedes LspA cleav-
age (58). Therefore, we propose that the slowest-migrating
species in the secA2 mutant, form X, and the globomycin-
shifted species of the wild type are lipidated, uncleaved pre-
cursors (Fig. 6A and C), while the slightly faster-migrating
form (form P) is an unlipidated, uncleaved precursor. This
experiment also revealed that in the membrane fraction of the
secA2 mutant there was a minor protein species that comi-
grated with form M and was globomycin sensitive (Fig. 6C,
lanes 11 and 12). Therefore, even in the absence of SecA2 a
small portion of Msmeg1712-HA appears to be correctly ex-
ported and processed.
SecA2 does not have a global effect on lipoprotein export.
Evaluation of the 1D protein profiles of Triton X-114 extracts
suggested that SecA2 does not have a global effect on the
export of all lipoproteins (Fig. 5). To test this more directly, we
studied the effect of SecA2 on the export and processing of two
proven lipoproteins of mycobacteria: the endogenous alkaline
phosphatase of M. smegmatis (PhoAMsmeg) (24) and the 19-
kDa lipoprotein (16, 61). M. smegmatis wild-type and secA2
strains were transformed with pML440 (59), a multicopy plas-
mid expressing PhoAMsmeg, or with pHSG67, a multicopy plas-
mid expressing the 19-kDa lipoprotein. Unlike Msmeg1712
and Msmeg1704, the localization of these lipoproteins to sub-
cellular fractions or Triton X-114 fractions was not influenced
by SecA2 (Fig. 4A and 5B). Furthermore, neither protein ac-
cumulated slower-migrating species in the secA2 mutant (Fig.
4). Likewise, MspA, a nonlipidated exported protein with a
conventional signal sequence and the major porin of M. smeg-
FIG. 5. Msmeg1712 and Msmeg1704 behave as lipoproteins in Tri-
ton X-114 fractionation. Triton X-114 partition experiments were per-
formed with native or epitope-tagged proteins. (A) M. smegmatis wild-
type strain (WT), secA2 mutant (), and complemented secA2
mutant (c) were grown in Mueller-Hinton broth and subjected to
Triton X-114 fractionation. The whole-cell lysate (WCL), Triton X-114
detergent phase (Tx114), and aqueous phase (Aq) were run on a
1D-PAGE gel and stained with Coomassie blue. The arrow indicates
the SecA2-dependent band identified as Msmeg1712. (B) Immunoblot
analysis of Triton X-114 fractions prepared from the M. smegmatis wild
type and the secA2 mutant expressing Msmeg1712-HA, Msmeg1704-
HA, or 19-kDa lipoprotein. Each blot is representative of three inde-
pendent experiments.
5096 GIBBONS ET AL. J. BACTERIOL.
matis (52), localized to the cell wall in both the wild-type and
mutant strains.
SecA2 in M. tuberculosis can recognize Msmeg1704-HA. To
test whether the SecA2 pathway of M. tuberculosis can recog-
nize SecA2-dependent proteins of M. smegmatis, we expressed
Msmeg1704-HA in wild-type and secA2 M. tuberculosis
strains and assayed protein localization by immunoblotting.
Subcellular fractions were generated by differential ultracen-
trifugation as they were with M. smegmatis, and they were
probed for GroEL2, a marker for the cytoplasm, Msmeg1704-
HA, and the known 19-kDa and PhoS1 lipoproteins, which are
envelope associated (16, 51). When Msmeg1704-HA was ex-
pressed in M. tuberculosis, its localization pattern was the same
as that observed in wild-type M. smegmatis (Fig. 7): present in
the cell wall and membrane fractions and absent in the soluble
fraction. Unlike what was seen in M. smegmatis, the absence of
SecA2 in M. tuberculosis did not have a pronounced effect on
localization to the cell wall and membrane fractions. However,
the amount of Msmeg1704-HA detected in the soluble fraction
increased, as was the case in M. smegmatis. Additionally, in the
secA2 mutant of M. tuberculosis, a slower-migrating species of
Msmeg1704-HA was present that comigrated with the slower
species seen in the secA2 mutant of M. smegmatis (Fig. 7 and
data not shown). This suggests that the SecA2 system of M.
tuberculosis is able to recognize the heterologous M. smegmatis
protein and contribute to its processing and export. This was
not the case with the other mycobacterial lipoproteins tested,
namely, the 19-kDa lipoprotein and PhoS1.
DISCUSSION
In this study, we expanded our search for substrates of the
mycobacterial SecA2 export system and identified two new
SecA2-dependent proteins: Msmeg1712 and Msmeg1704. This
work broadens our appreciation of the types of substrates that
can be exported by SecA2 of mycobacteria. Both Msmeg1712
FIG. 6. Globomycin sensitivity of mycobacterial lipoproteins. (A) Model for lipoprotein processing based on E. coli studies (60). The
unlipidated uncleaved precursor (form P), the lipidated uncleaved precursor (form X), and the mature form (form M) are indicated. Not shown
is the possibility of further lipid modification of form M at the exposed N terminus. The prolipoprotein diacylglyceryltransferase (Lgt) transfers
the lipid moiety to the free sulfhydryl group. Globomycin inhibits the lipoprotein signal peptidase (LspA). (B) M. smegmatis wild type expressing
the 19-kDa lipoprotein, Msmeg1712-HA, Msmeg1704-HA, or truncated ss-Msmeg1712-HA was grown in the presence () or absence () of
50 g/ml globomycin. Whole-cell lysates were separated by 1D-PAGE and probed with anti-HA or anti-19-kDa antibody. (C) Fractionation of the
wild type or secA2 mutant expressing Msmeg1712-HA grown in the presence or absence of 20 g/ml globomycin. Whole-cell lysates (WCL)
prepared by French pressure lysis were fractionated into cell wall (CW), membrane (M), and soluble (Sol) fractions. The following amounts of
material were loaded so that less abundant species could be visualized in the cell wall and membrane fractions: whole-cell lysate, 15 g; cell wall,
2.4 g; membrane, 4.1 g; and soluble fraction, 11.3 g. The positions of forms M, X, and P are indicated. The boxed region identifies the minor
globomycin-sensitive mature species detected in the secA2 mutant. The lower panel is a shorter exposure of lanes 9 to 12 showing forms M, X,
and P. The blots are representative of two independent experiments.
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and Msmeg1704 are lipoproteins that are localized to the cell
envelope by a SecA2-dependent process that requires an
amino-terminal signal sequence. In addition to being the first
cell envelope proteins identified as SecA2 dependent in myco-
bacteria, these lipoproteins are the first endogenous SecA2-
dependent proteins identified in M. smegmatis. Both of these
proteins share homology to monosaccharide-binding proteins.
The close proximity on the genome of their coding sequences,
their association with genes encoding components of ABC trans-
porters, and the sugar-regulated expression of Msmeg1712 sug-
gest a role for this genomic region in sugar uptake.
A proteomic approach was employed to identify Msmeg1712
and Msmeg1704 as being SecA2 dependent. Since expression
of the Msmeg1712-HA and Msmeg1704-HA proteins and of
an msmeg1712-lacZ fusion was the same in wild-type and
secA2 mutant strains, we concluded that the results of our
proteomic experiments reflect a true export defect rather than
secondary effects of the secA2 mutation on gene expression.
Msmeg1712 and Msmeg1704 were identified in both mem-
brane and cell wall fractions. However, with our subcellular
fractions we were unable to distinguish whether the proteins
are present in both locations or if they are truly membrane
associated and detection in the cell wall was due to contami-
nation of the cell wall fraction with membrane. Preparation of
uncontaminated cell wall fractions of mycobacteria is difficult
(35, 37, 44). In assaying fractions for NADH oxidase activity, a
predicted marker of the cytoplasmic membrane, we detected
contamination of our cell wall fractions. Although the majority
of the total recovered NADH oxidase activity was in the mem-
brane (63%), the cell wall fraction also contained activity
(32%). In contrast, there was no evidence that the membrane
fraction or cell wall fractions were contaminated with soluble
protein. Cell wall (MspA) and soluble (GroEL2) proteins were
limited to the appropriate fractions.
In 1D and 2D profiles of membrane and cell wall fractions
numerous proteins were visualized, but only Msmeg1712 and
Msmeg1704 were clearly seen to be SecA2 dependent. The fact
that only a small subset of proteins was identified as SecA2
dependent in M. smegmatis is consistent with findings for other
bacteria that have a second SecA homolog, including our own
results for M. tuberculosis (6, 9, 11, 28, 29). However, we cannot
rule out the possibility that additional SecA2-dependent pro-
teins in M. smegmatis exist. Our 2D-PAGE analysis was limited
to proteins with a molecular mass of less than 	100 kDa. In
addition, membrane and cell wall fractions are intrinsically
difficult to extract and resolve by PAGE. Hydrophobic mem-
brane proteins often precipitate at their isoelectric point and
fail to enter the second dimension during 2D-PAGE analysis
(21, 48). For these reasons, some SecA2-dependent proteins
may have been missed. Finally, our data indicate that growth
conditions can dramatically affect the ability to detect SecA2-
dependent proteins.
By expressing a truncated (ss)-Msmeg1712-HA protein
we showed that the predicted amino-terminal lipoprotein sig-
nal sequence of the substrate is required for export. Further,
the behavior of Msmeg1712 and Msmeg1704 in Triton X-114
partitioning and globomycin treatment experiments indicates
that they are genuine lipoproteins subject to cleavage by LspA.
This demonstrates that lipoproteins can be substrates of the
mycobacterial SecA2 export system. Notably, there did not
appear to be a global role for SecA2 in lipoprotein export or
processing; rather, the effect of SecA2 was specific for these
two lipoproteins. An interesting similarity is that four pre-
dicted lipoproteins are among the exported proteins identified
as dependent on SecA2 in L. monocytogenes (28). To our
knowledge, globomycin has not previously been used in myco-
bacteria. Our study revealed that this compound is a useful tool
for studying the lipoproteins of mycobacteria.
The secA2 mutation resulted in an export defect for
Msmeg1712-HA and Msmeg1704-HA such that the amount of
these proteins present in the cell wall, membrane, and Triton
X-114 fractions was significantly reduced, while the amount of
these proteins increased in the soluble and aqueous fractions.
Forms P and X were also observed in the secA2 mutant.
Additional studies are required to define the molecular iden-
tities of the form P, X, and M species observed in this study.
However, the simplest explanation is that forms P and X rep-
resent uncleaved export intermediates and form M is a mature
processed lipoprotein. We propose that the faster-migrating
form P is an unlipidated uncleaved precursor and that the
slower-migrating form X, which comigrated with the globomy-
cin-elicited product in wild-type M. smegmatis, is a lipidated
uncleaved precursor. Form M was sensitive to globomycin, and
it comigrated with the truncated (ss)-Msmeg1712-HA, which
is consistent with this species being mature and processed by
the LspA peptidase (Fig. 6C).
A model to explain our findings is as follows. The efficient
delivery to and transit through the membrane of Msmeg1712
and Msmeg1704 are dependent on SecA2. In the absence of
SecA2, a reduced amount of precursor reaches the membrane-
bound export machinery and instead accumulates in the cy-
tosol (form P). The residual export that occurs in the secA2
mutant is inefficient; less protein is correctly localized or pro-
cessed. A minor amount of globomycin-sensitive form M and
intermediates (forms P and X) are found in the membrane of
the secA2 mutant (Fig. 4B and 6C). The detection of export
intermediates in the membrane suggests that they are in the
process of engaging the export machinery to cross the mem-
brane. At least in E. coli, lipid modification requires a func-
tional Sec pathway and is thought to occur during or after
FIG. 7. SecA2-dependent processing of Msmeg1704-HA in M. tu-
berculosis. M. tuberculosis wild-type (H37Rv) (WT) and secA2 mutant
() strains expressing Msmeg1704-HA were grown in 7H9 medium
with albumin-dextrose-saline, disrupted in a French press, and frac-
tionated by differential ultracentrifugation. Proteins were resolved by
1D-PAGE and analyzed by immunoblotting for the presence of
GroEL2, Msmeg1704-HA, the 19-kDa lipoprotein, and the PhoS1
lipoprotein. The material loaded in each lane corresponds to the same
number of cells. The blots are representative of two independent
experiments. WCL, whole-cell lysate; CW, cell wall; M, membrane;
Sol, soluble fraction.
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translocation (20). Thus, one explanation for the appearance
of form X is that it is a normally transient export intermediate
that accumulates during inefficient export in the secA2 mu-
tant. Due to the presence of a recognizable Sec signal sequence
on these substrates, the housekeeping SecA1 protein is an
attractive candidate for carrying out the residual export. How-
ever, it is also possible that the residual export occurs inde-
pendently of SecA1. While the model described above seems
plausible, our data cannot rule out other more complex possi-
bilities. For example, SecA2 may function in the export of the
specific lipoproteins, as well as participate directly in their
lipidation.
Given the close homology of SecA1 and SecA2, it is tempt-
ing to speculate that SecA2 works with the general Sec trans-
locase (SecYEG) to promote export of a subset of signal se-
quence-containing proteins. The signal sequence-containing
proteins may span a continuum from those completely inde-
pendent of SecA2 and exclusively reliant on SecA1 to those
with an absolute requirement for SecA2 with no contribution
of SecA1. In the middle of this continuum would be proteins
that are exported optimally when both SecA1 and SecA2 are
present. Consequently, we believe that Msmeg1712 and
Msmeg1704 have as-yet-undefined features that render them
heavily dependent on SecA2 for initial recognition and trans-
location through the SecYEG pore. However, it is also possible
that molecules other than the known components of the Sec
apparatus are involved in exporting SecA2-dependent sub-
strates.
In line with the idea that SecA2 can promote export of some
signal sequence-containing proteins are the results of a prior
study with M. smegmatis in which the effect of SecA2 on signal
sequence-containing PhoA (E. coli alkaline phosphatase)
fusion proteins was evaluated (8). In this study, the absence of
SecA2 resulted in a partial export defect for some, but not all,
of the fusion proteins tested. However, in M. tuberculosis the
SecA2-dependent proteins identified are secreted and lack rec-
ognizable signal sequences (9). An intriguing possibility is that
the role of SecA2 in the secretion of nonconventional sub-
strates by M. tuberculosis is in the export to the cell envelope of
a specific signal sequence-containing protein, which is itself a
component of a novel secretion system. We are currently
searching for SecA2-dependent cell envelope proteins of M.
tuberculosis, which may help define such a pathway. Alter-
natively, SecA2 in M. tuberculosis could have a more direct
role in the secretion of nonconventional proteins through
the SecYEG channel or through a novel pathway.
Here we also showed that the SecA2 system of M. tubercu-
losis can recognize some signal sequence-containing proteins,
as shown by the appearance of an export intermediate of
Msmeg1704-HA in the secA2 mutant of M. tuberculosis. As in
M. smegmatis, this export defect was limited to Msmeg
1704-HA among the lipoproteins tested, suggesting that at
least some of the molecular determinants for SecA2-depen-
dent export are shared between M. tuberculosis and M. smeg-
matis. Even though M. tuberculosis lacks an obvious homolog
of Msmeg1712 or Msmeg1704, its genome contains four genes
encoding proteins annotated as periplasmic sugar-binding pro-
teins and genes encoding as many as 99 proteins that contain
predicted lipoprotein signal sequences (55). The lipoprotein
fraction is an attractive candidate for our ongoing search for
SecA2-dependent proteins of M. tuberculosis. The results of
the current study should aid our efforts to identify SecA2-
dependent proteins of M. tuberculosis by emphasizing the need
to examine lipoproteins, cell envelope proteins, and multiple
growth conditions.
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